CLINICAL_TRIALS
trial_result
· 2013-02-28
Clinical Trial Update: CCI-779 in Treating Patients With Extensive-Stage Small Cell Lung Cancer [Phase 2]
Summary
An update on a Phase 2 trial evaluating CCI-779 (temsirolimus) in patients with extensive-stage small cell lung cancer.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Cancer Institute (NCI) | Conditions: Extensive Stage Small Cell Lung Cancer | Phase 2 | Status: COMPLETED